Literature DB >> 12791836

Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Hong Bin Kim1, Wan Beom Park, Ki Deok Lee, Young Joo Choi, Sang Won Park, Myoung-Don Oh, Eui-Chong Kim, Kang Won Choe.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) accounts for more than 70% of S. aureus isolates from tertiary hospitals in Korea. Clinical isolates of S. aureus were collected from eight provincial, university-affiliated hospitals during the period from June 1999 to January 2001 for nationwide surveillance. All isolates were screened for reduced susceptibility to vancomycin by using brain heart infusion agar containing 4 micro g of vancomycin per milliliter. Population analysis and the determination of the MIC of vancomycin were done for the isolates which grew on the screening agar plates. Of 682 total isolates, MRSA accounted for 64% (439 of 682). Of 27 (4%) isolates that grew on the screening agar plates, none showed the heteroresistance phenotype. No strains with reduced susceptibility to vancomycin were identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791836      PMCID: PMC156475          DOI: 10.1128/JCM.41.6.2279-2281.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998.

Authors:  K Lee; C L Chang; N Y Lee; H S Kim; K S Hong; H C Cho
Journal:  Yonsei Med J       Date:  2000-08       Impact factor: 2.759

2.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.

Authors:  Sandra M Tallent; Tammy Bischoff; Michael Climo; Belinda Ostrowsky; Richard P Wenzel; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

Authors:  S S Wong; P L Ho; P C Woo; K Y Yuen
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

Review 6.  The emergence and evolution of methicillin-resistant Staphylococcus aureus.

Authors:  K Hiramatsu; L Cui; M Kuroda; T Ito
Journal:  Trends Microbiol       Date:  2001-10       Impact factor: 17.079

7.  Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

Authors:  J Ariza; M Pujol; J Cabo; C Peña; N Fernández; J Liñares; J Ayats; F Gudiol
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

8.  Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals.

Authors:  M E Reverdy; S Jarraud; S Bobin-Dubreux; E Burel; P Girardo; G Lina; F Vandenesch; J Etienne
Journal:  Clin Microbiol Infect       Date:  2001-05       Impact factor: 8.067

9.  Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.

Authors:  S K Hubert; J M Mohammed; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

10.  Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  S S Wong; T K Ng; W C Yam; D N Tsang; P C Woo; S K Fung; K Y Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2000-04       Impact factor: 2.803

View more
  15 in total

Review 1.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries.

Authors:  Kwan Soo Ko; Ji-Young Lee; Ji Yoeun Suh; Won Sup Oh; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital.

Authors:  Hwa Yun Cha; Dong Chan Moon; Chul Hee Choi; Jae Young Oh; Young Sook Jeong; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Hyun-Ha Chang; Shin-Woo Kim; Je Chul Lee
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.

Authors:  Adam M Pitz; Fang Yu; Elizabeth D Hermsen; Mark E Rupp; Paul D Fey; Keith M Olsen
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

5.  Genetic correlation of community-associated methicillin-resistant Staphylococcus aureus strains from carriers and from patients with clinical infection in one region of Korea.

Authors:  In-Gyu Bae; Jae Seok Kim; Sunjoo Kim; Sang Taek Heo; Chulhun Chang; Eun-Yup Lee
Journal:  J Korean Med Sci       Date:  2010-01-21       Impact factor: 2.153

Review 6.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.

Authors:  Adina C Musta; Kathleen Riederer; Stephen Shemes; Patrick Chase; Jinson Jose; Leonard B Johnson; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

8.  Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.

Authors:  Wenjia Sun; Hongbin Chen; Yudong Liu; Chunjiang Zhao; Wright W Nichols; Minjun Chen; Jianzhong Zhang; Yue Ma; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

9.  In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey.

Authors:  Hong Bin Kim; Hee-Chang Jang; Hee Jung Nam; Yeong Seon Lee; Bong Su Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Comparison of genotypes and enterotoxin genes between Staphylococcus aureus isolates from blood and nasal colonizers in a Korean hospital.

Authors:  Kyong Ran Peck; Jin Yang Baek; Jae-Hoon Song; Kwan Soo Ko
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.